A phase II study of olaparib in patients (pts) with advanced biliary tract cancer (aBTC) with aberrant homologous recombinant repair (HRR) mutations Meeting Abstract
| Authors: | Ahn, D.; Ulrich, A.; Park, W.; McCue, S.; Ou, F. S.; Tran, N.; Fonkoua, L. A. K.; Borad, M. J.; Bekaii-Saab, T.; Javle, M. |
| Abstract Title: | A phase II study of olaparib in patients (pts) with advanced biliary tract cancer (aBTC) with aberrant homologous recombinant repair (HRR) mutations |
| Meeting Title: | ESMO Gastrointestinal Cancers Congress Congress 2025 |
| Journal Title: | Annals of Oncology |
| Volume: | 36 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Jul 2-5 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2025-07-01 |
| Start Page: | S102 |
| End Page: | S103 |
| Language: | English |
| ACCESSION: | WOS:001545612500102 |
| DOI: | 10.1016/j.annonc.2025.05.276 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 261MO -- Source: Wos |
